Li J, Cao F, Yin H, Huang Z, Lin Z, Mao N, et al
Currently, only approximately 7.7% of non-Medicare plan members are accessing GLP-1s for weight loss through the citys health insurance yet this utilization represents approximately 14.7% of the projected cost increase from FY26 to FY27, with GLP-1 for weight loss costs estimated at $31.6 million for FY26 and rising to approximately $47.4 million in FY27, the CFO added
Losing weight is one of the most effective ways to lower cholesterol, and semaglutide aids in weight loss by reducing appetite and helping patients feel full longer
Alm disso, pessoas com histrico de pancreatite, distrbios da tireide, insuficincia renal grave e gestantes ou lactantes devem ter cautela e, em alguns casos, evitar o uso da semaglutida